You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune therapy naive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting Trial in Lausanne (Pembrolizumab, Pembrolizumab - additional

Active, not recruiting
  • Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
  • Lausanne, Switzerland
    Olivier Michielin
Jan 17, 2022

Advanced Solid Tumor Trial (INCB099280)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 19, 2023

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Malaria Trial (BNT165e, Placebo)

Not yet recruiting
  • Malaria
  • BNT165e
  • Placebo
  • (no location specified)
Sep 29, 2023

Bladder Cancer, Urothelial Carcinoma, Solid Tumor Trial in Worldwide (IPI-549 (eganelisib), Nivolumab, Placebos)

Active, not recruiting
  • Bladder Cancer
  • +3 more
  • IPI-549 (eganelisib)
  • +2 more
  • Fort Wayne, Indiana
  • +28 more
Apr 1, 2022

Recovery From Acute Immune Failure in Septic Shock by Immune

Recruiting
  • Severe Sepsis
    • Magdeburg, Germany
    • +1 more
    Nov 20, 2023

    Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)

    Completed
    Has Results
    • Helicobacter Pylori Infection
    • New York, New York
      Mount Sinai Union Square Division of Digestive Diseases
    Jan 6, 2023

    Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

    Completed
    • Covid-19 Patients
    • Cupping therapy with convential medical treatment
    • Convential medical treatment
    • Giza, Egypt
      Faculty of physical therapy
    Jun 11, 2023

    HIV Infection Trial in Seville (Randomize)

    Recruiting
    • HIV Infection
    • Seville, Spain
      Hospital Universitario Virgen del Rocio
    Aug 14, 2020

    Immune System Disorder Trial in Giza (Aerobic training, diet protocol)

    Recruiting
    • Immune System Disorder
    • Aerobic training
    • diet protocol
    • Giza, Egypt
      Faculty of Physical therapy, Cairo University
    Nov 20, 2023

    Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

    Active, not recruiting
    • Non-muscle-invasive Bladder Cancer
    • Gemcitabine 1000 mg, Docetaxel 37.5g
    • Zagreb, Croatia
      University Hospital Centre Zagreb
    Jan 20, 2023

    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

    Active, not recruiting
    • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    May 17, 2023

    Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

    Recruiting
    • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
    • Radiotherapy
    • +2 more
    • Rozzano, Milano, Italy
      Humanitas Research Hospital
    May 3, 2022

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)

    Recruiting
    • Severe Aplastic Anemia
    • Hetrombopag Olamine+Standard Therapy
    • Placebo+Standard Therapy
    • Tianjin, Tianjin, China
      Blood Diseases Hospital, Chinese Academy of Medical Sciences
    Jul 28, 2022

    Immune Checkpoint Inhibitor Monotherapy or Combined With

    Not yet recruiting
    • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jan 30, 2023

    AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

    Recruiting
    • AIDS Virus
    • Disorder of Immune Reconstitution
    • normal saline
    • Mesenchymal stem cells
    • Jinan, Shandong, China
      Shandong Public Health Clinical Center
    May 14, 2023

    Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone

    Active, not recruiting
    • Last Period Not Earlier Than 6 Months Ago
    • oral menopausal hormone therapy
    • transdermal menopausal hormone therapy
    • Moscow, Russian Federation
      Federal State Budget Institution Research Center for Obstetrics,
    Jan 9, 2023

    Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)

    Recruiting
    • Actinic Keratosis
    • Photodynamic Therapy
    • Celecoxib 200mg
    • Placebo
    • Fairborn, Ohio
      Wright State Physicians
    Jan 9, 2023

    HIV Positive Trial in Saint-etienne (blood and urinary samples)

    Not yet recruiting
    • HIV Positive
    • blood and urinary samples
    • Saint-etienne, France
      Chu Saint-Etienne
    Nov 29, 2022

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023